Diversion Control Division, US Department of Justice, Drug Enforcement Administration

Manufacturers Notice of Registration - 2015

[Federal Register Volume 80, Number 16 (Monday, January 26, 2015)]
[Notices]
[Pages 3984-3985]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-01304]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]

Manufacturer of Controlled Substances Registration: Mallinckrodt, LLC

ACTION: Notice of registration.


SUMMARY: Mallinckrodt, LLC applied to be registered as a manufacturer of certain basic classes of controlled substances. The DEA grants Mallinckrodt, LLC registration as a manufacturer of those controlled substances.

SUPPLEMENTARY INFORMATION: By notice dated May 28, 2014, and published in the Federal Register on June 3, 2014, 79 FR 31986, Mallinckrodt, LLC, 3600 North Second Street, St. Louis, Missouri 63147, applied to be registered as a manufacturer of certain basic classes of controlled substances. No comments or objections were submitted to this notice.

The Drug Enforcement Administration (DEA) has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Mallinckrodt, LLC to manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history.

Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of the basic classes of controlled substances:

Controlled Substance Schedule
Tetrahydrocannabinols (7370) I
Codeine-N-oxide (9053) I
Dihydromorphine (9145) I
Difenoxin (9168) I
Morphine-N-oxide (9307) I
Normorphine (9313) I
Norlevorphanol (9634) I
Amphetamine (1100) II
Methamphetamine (1105) II
Methylphenidate (1724) II
Nabilone (7379) II
4-Anilino-N-phenethyl-4-piperidine (8333) II
Codeine (9050) II
Dihydrocodeine (9120) II
Oxycodone (9143) II
Hydromorphone (9150) II
Diphenoxylate (9170) II
Ecgonine (9180) II
Hydrocodone (9193) II
Levorphanol (9220) II
Meperidine (9230) II
Methadone (9250) II
Methadone intermediate (9254) II
Dextropropoxyphene, bulk (non-dosage forms) (9273) II
Morphine (9300) II
Thebaine (9333) II
Opium tincture (9630) II
Opium, powdered (9639) II
Oxymorphone (9652) II
Noroxymorphone (9668) II
Alfentanil (9737) II
Remifentanil (9739) II
Sufentanil (9740) II
Fentanyl (9801) II

[[Page 3985]]

The company plans to manufacture the listed controlled substances for internal use and for distribution to other companies.

Dated: January 9, 2015.

Joseph T. Rannazzisi,
Deputy Assistant Administrator.

[FR Doc. 2015-01304 Filed 1-23-15; 8:45 am]

BILLING CODE 4410-09-P

 

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Printing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility